Article and Video CATEGORIES
Understanding how tumors respond to radiation has been a lifelong process for Puneeth Iyengar, M.D., Ph.D., Assistant Professor of Radiation Oncology at UT Southwestern Medical Center. He began testing theories in school science fairs as an adolescent growing up in Louisiana. Studying at MIT furthered his interest in the biologic and engineering aspects of medicine, and he earned a bachelor of science degree in biology before receiving his M.D./Ph.D. degrees from Albert Einstein College of Medicine in New York in 2005.
In these video series, Dr. Iyengar discusses two indications, or timepoints, where radiation and/or surgery may be used to improve the survival outcomes in metastatic, non-small cell lung cancer (NSCLC) patients, specifically focusing on consolidation. He discusses various trials, but also the importance of how radiation would help patients who were receiving immunotherapy-based regiments. This led to the discussion of NRG-LU002, a randomized phase II/III trial of maintenance systemic therapy vs. local consolidative therapy (LCT) plus maintenance systemic therapy for limited metastatic non-small cell lung cancer (NSCLC).
He also discusses how biology affects non-small cell lung cancer (NSCLC) outcomes, the results of NRG-LU002, a randomized phase II/III trial of maintenance systemic therapy vs. local consolidative therapy (LCT) plus maintenance systemic therapy for limited metastatic non-small cell lung cancer (NSCLC), and how to select patients for the optimal therapy for metastatic non-small cell lung cancer (NSCLC).
To watch the complete playlist, click here.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
